基本信息
浏览量:60
职业迁徙
个人简介
Suresh’s main research interests are in understanding how therapies alter brain activity and in developing methodologies to measure these changes in both healthy individuals and patient groups - particularly patients with depression. His previous studies have involved a range of compounds including hallucinogens (ketamine, LSD, psilocybin), anaesthetics (propofol, dexmedetomidine), anti-epileptics (vigabatrin, perampanel, tiagabine) and GABA-enhancers (zolpidem, gaboxadol). Suresh’s research has used a wide-range of neuroimaging techniques including magnetoencephalography, electroencephalography, functional magnetic resonance imaging and magnetic resonance spectroscopy.
研究兴趣
论文共 180 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BMC Neuroscienceno. 1 (2024): 1-14
BMC Neuroscienceno. 1 (2024): 1-14
Translational Psychiatryno. 1 (2024): 1-10
Biological psychiatry (2023)
Journal of Psychopharmacologyno. 9 (2023): 891-903
引用0浏览0引用
0
0
Nathan Allen, Aron Jeremiah, Robin Murphy,Rachael Sumner,Anna Forsyth,Nicholas Hoeh,David B Menkes,William Evans,Suresh Muthukumaraswamy,Frederick Sundram,Partha Roop
medRxiv (Cold Spring Harbor Laboratory) (2023)
引用0浏览0引用
0
0
Expert review of clinical pharmacologypp.1-11, (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn